Thrombotic events in patients using cyclin dependent kinase 4/6 inhibitors, analysis of existing ambulatory risk assessment models and the potential influences of tumor specific risk factors-Reference-Cited by-同舟云学术

Thrombotic events in patients using cyclin dependent kinase 4/6 inhibitors, analysis of existing ambulatory risk assessment models and the potential influences of tumor specific risk factors

Published:2022-04 Issue:2 Volume:46 Page:100832
ISSN:0147-0272
Container-title:Current Problems in Cancer
language:en
Short-container-title:Current Problems in Cancer

Author:

West Malinda T.^ORCID,Kartika Thomas^ORCID,Paquin Ashley R.,Liederbauer Erik,Zheng Tony J.^ORCID,Lane Lucy,Thein Kyaw^ORCID,Shatzel Joseph J.

Funder

National Heart, Lung, and Blood Institute

National Institutes of Health

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference82 articles.

1. Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy;Khorana;J. Thromb. Haemost.,2007

2. Rates of initial and recurrent thromboembolic disease among... : medicine;Levitan;Medicine (Baltimore),1999

3. Prognosis of Cancers Associated with Venous Thromboembolism;Sørensen;N. Engl. J. Med.,2000

4. Lee AYY, Levine MN. 2003. Venous thromboembolism and cancer: risks and outcomes

5. association between genetic mutations and risk of venous thromboembolism in patients with solid tumor malignancies: a systematic review and meta-analysis;Abufarhaneh;Blood,2020

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Managing Cardiovascular and Cancer Risk Associated with JAK Inhibitors;Drug Safety;2023-07-25

2. Cyclin-dependent kinase 4/6 inhibitor-associated thromboembolism: a critical evaluation of the current evidence;Journal of Thrombosis and Haemostasis;2023-04